| Year |
Citation |
Score |
| 2004 |
Whiteside GT, Harrison JE, Pearson MS, Chen Z, Fundytus ME, Rotshteyn Y, Turchin PI, Pomonis JD, Mark L, Walker K, Broglé KC. DiPOA ([8-(3,3-diphenyl-propyl)-4-oxo-1-phenyl-1,3,8-triazaspiro[4.5]dec-3-yl]-acetic acid), a novel, systemically available, and peripherally restricted Mu opioid agonist with antihyperalgesic activity: II. In vivo pharmacological characterization in the rat. The Journal of Pharmacology and Experimental Therapeutics. 310: 793-9. PMID 15054116 DOI: 10.1124/jpet.103.063560 |
0.45 |
|
| 2003 |
Sharma SK, Yashpal K, Fundytus ME, Sauriol F, Henry JL, Coderre TJ. Alterations in brain metabolism induced by chronic morphine treatment: NMR studies in rat CNS. Neurochemical Research. 28: 1369-73. PMID 12938859 DOI: 10.1023/A:1024996415795 |
0.595 |
|
| 2002 |
Fundytus ME, Osborne MG, Henry JL, Coderre TJ, Dray A. Antisense oligonucleotide knockdown of mGluR1 alleviates hyperalgesia and allodynia associated with chronic inflammation. Pharmacology, Biochemistry, and Behavior. 73: 401-10. PMID 12117595 DOI: 10.1016/S0091-3057(02)00831-6 |
0.673 |
|
| 2002 |
Sharif RN, Osborne M, Coderre TJ, Fundytus ME. Attenuation of morphine tolerance after antisense oligonucleotide knock-down of spinal mGluR1. British Journal of Pharmacology. 136: 865-72. PMID 12110611 DOI: 10.1038/sj.bjp.0704792 |
0.715 |
|
| 2001 |
Fundytus ME. Glutamate receptors and nociception: implications for the drug treatment of pain. Cns Drugs. 15: 29-58. PMID 11465012 DOI: 10.2165/00023210-200115010-00004 |
0.426 |
|
| 2001 |
Fundytus ME, Yashpal K, Chabot JG, Osborne MG, Lefebvre CD, Dray A, Henry JL, Coderre TJ. Knockdown of spinal metabotropic glutamate receptor 1 (mGluR(1)) alleviates pain and restores opioid efficacy after nerve injury in rats. British Journal of Pharmacology. 132: 354-67. PMID 11156596 DOI: 10.1038/sj.bjp.0703810 |
0.733 |
|
| 2000 |
Fundytus ME. Common mechanisms underlying opioid tolerance and dependence, and neuropathic pain: Role of metabotropic glutamate receptors Pain Research and Management. 5: 40-48. |
0.483 |
|
| 1999 |
Schiller PW, Fundytus ME, Merovitz L, Weltrowska G, Nguyen TM, Lemieux C, Chung NN, Coderre TJ. The opioid mu agonist/delta antagonist DIPP-NH(2)[Psi] produces a potent analgesic effect, no physical dependence, and less tolerance than morphine in rats. Journal of Medicinal Chemistry. 42: 3520-6. PMID 10479285 DOI: 10.1021/jm980724+ |
0.65 |
|
| 1999 |
Fundytus ME, Coderre TJ. mGluRs and opioid dependence Pain Forum. 8: 59-63. DOI: 10.1016/S1082-3174(99)70049-8 |
0.635 |
|
| 1999 |
Fundytus ME, Coderre TJ. Opioid tolerance and dependence Pain Forum. 8: 3-13. DOI: 10.1016/S1082-3174(99)70013-9 |
0.678 |
|
| 1999 |
Fundytus ME, Coderre TJ. mGluRs and opioid dependence: A further examination of the mechanisms Pain Forum. 8: 59-63. |
0.637 |
|
| 1999 |
Fundytus ME, Coderre TJ, Mayer DJ, Mao J, Blackburn-Munro G, Yaksh TL, Marsala M, Ibuki T, Vaccarino AL, Trujillo KA. Opioid tolerance and dependence: A new model highlighting the role of metabotropic glutamate receptors Pain Forum. 8: 3-13. |
0.643 |
|
| 1998 |
Fisher K, Fundytus ME, Cahill CM, Coderre TJ. Intrathecal administration of the mGluR compound, (S)-4CPG, attenuates hyperalgesia and allodynia associated with sciatic nerve constriction injury in rats. Pain. 77: 59-66. PMID 9755019 DOI: 10.1016/S0304-3959(98)00082-7 |
0.697 |
|
| 1998 |
Fundytus ME, Fisher K, Dray A, Henry JL, Coderre TJ. In vivo antinociceptive activity of anti-rat mGluR1 and mGluR5 antibodies in rats. Neuroreport. 9: 731-5. PMID 9559947 DOI: 10.1097/00001756-199803090-00031 |
0.638 |
|
| 1997 |
Fundytus ME, Coderre TJ. Attenuation of precipitated morphine withdrawal symptoms by acute i.c.v. administration of a group II mGluR agonist. British Journal of Pharmacology. 121: 511-4. PMID 9179394 DOI: 10.1038/sj.bjp.0701174 |
0.622 |
|
| 1997 |
Fundytus ME, Ritchie J, Coderre TJ. Attenuation of morphine withdrawal symptoms by subtype-selective metabotropic glutamate receptor antagonists. British Journal of Pharmacology. 120: 1015-20. PMID 9134211 DOI: 10.1038/sj.bjp.0701000 |
0.655 |
|
| 1996 |
Fundytus ME, Coderre TJ. Chronic inhibition of intracellular Ca2+ release or protein kinase C activation significantly reduces the development of morphine dependence. European Journal of Pharmacology. 300: 173-81. PMID 8739205 DOI: 10.1016/0014-2999(95)00871-3 |
0.657 |
|
| 1995 |
Fundytus ME, Schiller PW, Shapiro M, Weltrowska G, Coderre TJ. Attenuation of morphine tolerance and dependence with the highly selective delta-opioid receptor antagonist TIPP[psi]. European Journal of Pharmacology. 286: 105-8. PMID 8566146 DOI: 10.1016/0014-2999(95)00554-X |
0.663 |
|
| 1994 |
Fundytus ME, Coderre TJ. Effect of activity at metabotropic, as well as ionotropic (NMDA), glutamate receptors on morphine dependence. British Journal of Pharmacology. 113: 1215-20. PMID 7889275 DOI: 10.1111/J.1476-5381.1994.Tb17127.X |
0.678 |
|
| 1994 |
Fundytus M, Schiller P, Shapiro M, Weltrowska G, Coderre T. The novel and highly selective δ-opioid antagonist TIPP(ψ) attenuates morphine tolerance and dependence: Comparison with the effects of naltrindole and TIPP Regulatory Peptides. 54: 97-98. DOI: 10.1016/0167-0115(94)90407-3 |
0.44 |
|
| 1993 |
Coderre TJ, Fundytus ME, McKenna JE, Dalal S, Melzack R. The formalin test: a validation of the weighted-scores method of behavioural pain rating. Pain. 54: 43-50. PMID 8378102 DOI: 10.1016/0304-3959(93)90098-A |
0.608 |
|
| Show low-probability matches. |